BitFuFu to Attend Upcoming Investor Conferences in September
06. September 2024 06:30 ET
|
BitFuFu Inc.
Singapore, Sept. 06, 2024 (GLOBE NEWSWIRE) -- BitFuFu, Inc. (NASDAQ: FUFU, FUFU.WS) (“BitFuFu” or the “Company”) a fast-growing digital asset mining service and world-leading...
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
03. September 2024 16:01 ET
|
Genelux Corporation
WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President,...
Revolution Medicines to Participate in Upcoming Investor Conferences
09. November 2022 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
AppTech Payments Corp. to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06. September 2022 06:00 ET
|
AppTech Corp.
CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (AppTech) (NASDAQ: APCX), an innovative Fintech company powering commerce experiences, today announced its Chairman and...
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
23. Mai 2022 06:30 ET
|
Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Monopar Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020
14. September 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced that Chandler D. Robinson, MD, Chief Executive Officer, will present a corporate update at...
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
11. September 2020 15:00 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
09. September 2020 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted therapies to inhibit...
Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
24. August 2020 08:00 ET
|
Cancer Genetics, Inc.
Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions RUTHERFORD, NJ and MAPLE GROVE, MN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the...